Skip to main content
. Author manuscript; available in PMC: 2015 Feb 1.
Published in final edited form as: Clin Gastroenterol Hepatol. 2013 Aug 27;12(2):239–245. doi: 10.1016/j.cgh.2013.08.029

Table 2.

Associations of H pylori and cagA Seroprevalence with Symptoms of Gastroesophageal Reflux, Erosive Esophagitis, or Barrett’s Esophagus.

H pylori /
cagA Status
# No GERD,
EE, or BEb
GERD Erosive Esophagitis Barrett’s Esophagus
# GERD Crude OR
(95% CI)
Adjusted
OR (95% CI)a
# EE Crude OR
(95% CI)
Adjusted
OR (95% CI)
# BEb Crude OR
(95% CI)
Adjusted
OR (95% CI)
H pylori 131 115 1 (Reference) 1 (Reference) 182 1 (Reference) 1 (Reference) 125 1 (Reference) 1 (Reference)
H pylori + 46 38 0.94
(0.57, 1.55)
0.95
(0.55, 1.64)
40 0.63
(0.39, 1.01)
0.63
(0.37, 1.08)
25 0.57
(0.33, 0.98)
0.53
(0.29, 0.97)
  H pylori +, cagA − 22 20 1.04
(0.54, 1.99)
0.93
(0.46, 1.88)
25 0.82
(0.44, 1.51)
0.78
(0.40, 1.54)
16 0.76
(0.38, 1.52)
0.64
(0.30, 1.36)
  H pylori +, cagA + 23 18 0.89
(0.46, 1.74)
0.97
(0.46, 2.03)
15 0.47
(0.24, 0.93)
0.47
(0.21, 1.03)
8 0.365
(0.16, 0.85)
0.36
(0.14, 0.90)
a

Adjusted for age, waist-to-hip ratio, smoking status, education, and race.

BE: Barrett’s esophagus, CI: confidence interval, GERD: gastroesophageal reflux disease, EE: erosive esophagitis, OR: odds ratio

b

1 normal patient and 1 with BE was positive for H pylori, but had inadequate sample for assaying cagA.